Knox, J. J., Barrios, C. H., Kim, T. M., Cosgriff, T., Srimuninnimit, V., Pittman, K., . . . Motzer, R. J. (2018). Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC. Ann Oncol.
Stile di citazione ChicagoKnox, J J., et al. "Final Overall Survival Analysis for the Phase II RECORD-3 Study of First-line Everolimus Followed By Sunitinib Versus First-line Sunitinib Followed By Everolimus in Metastatic RCC." Ann Oncol 2018.
Citazione MLAKnox, J J., et al. "Final Overall Survival Analysis for the Phase II RECORD-3 Study of First-line Everolimus Followed By Sunitinib Versus First-line Sunitinib Followed By Everolimus in Metastatic RCC." Ann Oncol 2018.